Illness	Number of cases
Malignant neoplasm of prostate (C61)	332
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	212
Hyperplasia of prostate (N40)	182
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	173
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	139
Calculus of kidney and ureter - Calculus of ureter (N20.1)	118
Calculus of kidney and ureter - Calculus of kidney (N20.0)	88
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5)	74
Other disorders of bladder (N32.8)	64
Malignant neoplasm of kidney except renal pelvis (C64)	41

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	632
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	622
Use of an imaging procedure during an operation (3-992)	481
Insertion, exchange or removal of a ureteral stent (8-137.10)	318
Insertion, exchange or removal of a ureteral stent (8-137.00)	292
Computed tomography (CT) of the abdomen without contrast medium (3-207)	267
Computed tomography of the abdomen with contrast medium (3-225)	225
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	199
(9-984.8)	188
(1-465.91)	185

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
48	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
39	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
25	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Lectureships / teaching posts at colleges and universities